Evidence map›Paper›PMID 27842524›Full record

ArticleBMC medical ethics2016

Introduction to the article collection 'Translation in healthcare: ethical, legal, and social implications'.

Michael Morrison, Donna Dickenson, Sandra Soo-Jin Lee

Abstract readEditorial
In one paragraph

Article in BMC medical ethics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Rethinking the ethical principles of genomic medicine services.European journal of human genetics : EJHG · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael MorrisonCentre for Health, Law and Emerging Technologies (HeLEX), Nuffield Department of Population Health, University of Oxford, Ewert House Banbury Road, Oxford, OX2 7DD, UK. michael.morrison@dph.ox.ac.uk.ORCID 0000-0001-6870-6673
Donna DickensonCentre for Health, Law and Emerging Technologies (HeLEX), Nuffield Department of Population Health, University of Oxford, Ewert House Banbury Road, Oxford, OX2 7DD, UK.
Sandra Soo-Jin LeeCenter for Biomedical Ethics, Stanford University School of Medicine, 1215 Welch Road MOD A Office 75, Stanford, CA, 94305, USA.

Funding

Wellcome Trust
6 · The paper itself

Abstract

New technologies are transforming and reconfiguring the boundaries between patients, research participants and consumers, between research and clinical practice, and between public and private domains. From personalised medicine to big data and social media, these platforms facilitate new kinds of interactions, challenge longstanding understandings of privacy and consent, and raise fundamental questions about how the translational patient pathway should be organised.This editorial introduces the cross-journal article collection "Translation in healthcare: ethical, legal, and social implications", briefly outlining the genesis of the collection in the 2015 Translation in healthcare conference in Oxford, UK and providing an introduction to the contemporary ethical challenges of translational research in biology and medicine accompanied by a summary of the papers included in this collection.

Indexed as

Bioethical IssuesCommunity ParticipationConfidentialityDelivery of Health CareEthics, ClinicalHumansInformed ConsentPrecision MedicinePrivacyResearch SubjectsSocial MediaTranslational Research, Biomedical

Identifiers

PMID27842524
PMCPMC5109837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.